Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
about
Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy.Comparative efficacy of rabeprazole and pantoprazole in the control of nocturnal Acid output and intragastric acidity.Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting.Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazolePharmacogenomics of antimicrobial agents.Drug-drug interaction between clopidogrel and the proton pump inhibitors.Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safetyThe effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.A review of rabeprazole in the treatment of acid-related diseasesReview article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.Genetic factors in the pathogenesis of gastroesophageal reflux disease.Proton pump inhibitors: impact on glucose metabolism.The chemically elegant proton pump inhibitorsA study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication.Letter: CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib-induced small bowel injury.Letter: CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib-induced small bowel injury-authors' reply.Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.Plasma concentration of rabeprazole after 8-week administration in gastroesophageal reflux disease patients and intragastric pH elevation.Effect of CYP2C19 genetic polymorphism on pharmacokinetics and pharmacodynamics of a new proton pump inhibitor, ilaprazole.Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.Rabeprazole: a pharmacologic and clinical review for acid-related disorders
P2860
Q33779762-659EC066-12B4-4B35-9CE8-35C355FEEDEEQ33855564-95C5CE60-AC8C-4B09-8F6C-AC286273ACA4Q33868511-4F4BA16E-2B96-4425-B63E-3B6F54A93B31Q33946261-25AB0CC5-A1C7-45B0-B817-1105B3167697Q34977413-505E8203-90B7-4985-A86E-CB2143812D44Q34983154-38CB140E-760A-495B-9205-430EC9DD34DCQ35167717-74858A8E-D21D-41E8-8E07-02E807D82FE5Q36545135-D12062A7-D89C-4A3C-8405-D91F87E2077BQ36661321-5125B68A-4F06-43A8-A0B5-EE2488FC17D5Q37799470-C3547F38-BA57-4182-B89A-C20B19F1330DQ37874455-077AE39B-3A76-42F7-87EA-664CA3401F73Q38034083-966E31F6-22A3-41B6-8827-3062A79AE40EQ39133807-B414F6BF-D5DC-44D0-AE4B-CA2854792062Q46879639-6AE13204-2028-4359-BE1F-DB4103535558Q47843202-B2273D99-2A77-4C55-9983-D76FD896FA65Q47843216-3F9D4275-B15D-46D5-9CC3-7C05A551C120Q49502751-BBB8EDEA-22DE-4D0A-82F7-270E32560626Q50680833-33605727-6594-42FC-9463-843DE2EA9878Q51461774-D5D02F14-ADF4-46D0-AD64-6D342E8FAF52Q55280841-BCE73B9F-E4DE-44DB-9808-199E4B4451BDQ56431955-B7AC5174-F912-4BF6-9E41-D650F70EC5B1
P2860
Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Review article: relationship b ...... ibitors--focus on rabeprazole.
@ast
Review article: relationship b ...... ibitors--focus on rabeprazole.
@en
type
label
Review article: relationship b ...... ibitors--focus on rabeprazole.
@ast
Review article: relationship b ...... ibitors--focus on rabeprazole.
@en
prefLabel
Review article: relationship b ...... ibitors--focus on rabeprazole.
@ast
Review article: relationship b ...... ibitors--focus on rabeprazole.
@en
P2860
P1476
Review article: relationship b ...... ibitors--focus on rabeprazole.
@en
P2093
P2860
P356
10.1111/J.1365-2036.2004.02161.X
P407
P478
20 Suppl 6
P577
2004-11-01T00:00:00Z